27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
NovoCure beat estimated earnings by 3.85%, reporting an EPS of $-0.25 versus an estimate of $-0.26.
Revenue was down $2.61 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 3.2% drop in the share price the next day.
Here's a look at NovoCure's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.18 | -0.10 | -0.07 |
| EPS Actual | -0.23 | -0.04 | -0.25 | -0.13 |
| Revenue Estimate | 134.99M | 134.08M | 135.42M | 141.76M |
| Revenue Actual | 140.87M | 137.55M | 133.21M | 133.61M |
To track all earnings releases for NovoCure visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.